To the shareholders of
The Annual General Meeting was held Wednesday
Notice: Represented at the annual general meeting was share capital of nominal
The agenda for the annual general meeting was as follows:
- ELECTION OF CHAIRMAN OF THE MEETING
- REPORT ON THE ACTIVITIES OF THE COMPANY IN THE PAST FINANCIAL YEAR
- PRESENTATION OF THE ANNUAL REPORT WITH AUDITORS' REPORT FOR ADOPTION
- RESOLUTION ON COVERING OF LOSSES IN ACCORDANCE WITH THE ADOPTED ANNUAL REPORT
- ELECTION OF MEMBERS TO THE BOARD OF DIRECTORS
- ELECTION OF THE COMPANY’S AUDITOR
- PROPOSALS FROM THE BOARD OF DIRECTORS AND SHAREHOLDERS
- Approval of the remuneration of the board of directors
- MISCELLANEOUS
Adoptions:
Re 1: Election of chairman of the meeting
The board of directors proposed that attorney-at-law Lars Lüthjohan was elected as the chairman of the general meeting.
The chairman of the meeting stated, with the unanimous consent of the general meeting, that the general meeting was lawfully convened and legally competent to resolve upon the following agenda:
Re 2: Report on the activities of the Company in the past financial year
An oral report on the activities of the Company in the past financial year was presented by CEO
Re 3: Presentation of the annual report with auditors' report for adoption
The Company's annual report with the auditors' report for the financial year 2023 was adopted.
Re 4: Resolution on covering of losses in accordance with the adopted annual report
The consolidated loss for the financial year 2023 of tDKK 38,377 was approved to be carried forward to the next financial year in accordance with the adopted annual report.
Re 5: Election of members to the board of directors
The general meeting re-elected the following members of the board of directors:
The general meeting also elected
The board of directors hereafter consists of the following members:
Peter Mørch Eriksen (chairman)- Mats Thorén (deputy chairman)
- Michael Thyrring Engsig
Andreas Kjær Donna Haire Roger Gunnarsson
Re 6: Election of auditor
PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab, CVR no. 39 29 64 38, was re-elected as the Company's auditor.
Re 7.1: Approval of the remuneration of the board of directors
The board of directors proposed that the board of directors shall receive remuneration for the financial year 2024 to be paid out at the annual general meeting of 2025.
The proposed remuneration is as follows:
DKK payment for the year 2024 | Warrants, up to | |
Chairman | 280,000 | 0 |
Vice Chairman | 200,000 | 0 |
Board member | 100,000 | 0 |
New board members may be offered | 80,000 | 7,500 |
The proposal was adopted by the general meeting.
Re 8: Miscellaneous
Nothing to note in the minutes.
For further information, please contact:
Phone: +45 24 25 62 66
E-mail: ma@fluoguide.com
Certified Adviser:
Phone: +46 70 755 95 51
E-mail: ca@skmg.se
About
The Company has published strong results from phase II trials demonstrating the efficacy of FG001 as well as showing it was well tolerated and safe from clinical trials in patients undergoing surgery to remove aggressive brain (high-grade glioma), head & neck and lung cancers. Based on this strong foundation,
© Modular Finance, source